20-F: AIFU Inc. Reports Steep 2025 Losses Amid Strategic Shift
Annual Report
AIFU Inc. reported a significant net loss of RMB 2.27 billion in 2025, a sharp decline from net income in 2024, driven by reduced revenues, substantial credit losses, and asset impairments, despite strategic divestitures and a focus on AI-driven insurance services.
Summary
- AIFU Inc. (formerly AIX Inc., Fanhua Inc., and CNinsure Inc.) changed its name to AIFU Inc. on April 17, 2025, reflecting a strategic repositioning.
- The company terminated its American Depositary Receipt (ADR) facility on May 20, 2025, and its Class A ordinary shares commenced trading on Nasdaq in substitution for ADSs on May 21, 2025.
- A 400-for-1 share consolidation was implemented on May 21, 2025, to regain compliance with Nasdaq's minimum bid price requirement, which was successfully achieved by June 5, 2025.
- The company disposed of its online insurance distribution platform (Baowang) in December 2024 and its claims adjusting business in January 2025, streamlining operations to focus on its core insurance agency business.
- AIFU Inc. acquired 100% of Nova Lumina Limited on January 9, 2026, for 102,578,839 Class A ordinary shares and a US$22.0 million cash payment, diversifying into the premium tea products sector within the health and wellness consumer market.
- Net revenues decreased by 58.2% from RMB 1,331.8 million in 2024 to RMB 556.6 million (US$79.6 million) in 2025.
- The company reported an operating loss of RMB 39.1 million (US$5.6 million) in 2025, a significant improvement from RMB 447.1 million operating loss in 2024, primarily due to substantial cost savings.
- Net loss attributable to shareholders was RMB 2,275.4 million (US$325.4 million) in 2025, a substantial reversal from a net income of RMB 455.0 million in 2024.
- The significant net loss was primarily driven by a provision for credit losses of RMB 1,560.1 million (US$223.1 million) and an impairment loss on financial assets of RMB 610.6 million (US$87.3 million) in 2025.
- The company issued 2,500,000 Class B ordinary shares on January 2, 2025, and an additional 5,000,000 Class B ordinary shares on December 22, 2025, to Expansion Group Ltd, which became the new controlling shareholder with 65.49% voting power.
- A private placement of 10,000,000 Class A ordinary shares was completed on July 23, 2025, raising capital for general working capital purposes.
- As of December 31, 2025, the company had 42,170 registered sales agents, a decrease from 58,398 in 2024.
- Management concluded that internal control over financial reporting was effective as of December 31, 2025.
Sentiment
Score: 2
Explanation: StockSavvy.ai views this filing with a highly negative sentiment due to the substantial net loss, significant revenue decline, and massive credit and asset impairment losses, which overshadow any strategic repositioning efforts.
Positives
- Successfully regained compliance with Nasdaq's minimum bid price requirement following a 400-for-1 share consolidation.
- Strategic divestitures of online insurance distribution and claims adjusting businesses allow for a sharpened focus on the core insurance agency segment.
- Acquisition of Nova Lumina Limited diversifies the company into the high-growth health and wellness consumer sector with a tangible asset base (premium tea inventory).
- Significant cost savings and operational efficiency improvements led to a reduced operating loss of RMB 39.1 million in 2025 compared to RMB 447.1 million in 2024.
- Successful private placement of Class A ordinary shares and issuance of Class B ordinary shares provided capital for working capital purposes.
- Management concluded that internal control over financial reporting was effective as of December 31, 2025, indicating sound financial governance.
Negatives
- Reported a substantial net loss of RMB 2,275.4 million (US$325.4 million) in 2025, a significant deterioration from net income of RMB 455.0 million in 2024.
- Total net revenues decreased significantly by 58.2% from RMB 1,331.8 million in 2024 to RMB 556.6 million (US$79.6 million) in 2025.
- Life insurance business revenues decreased by 56.5% due to prolonged weakness in consumer confidence and adverse impact of regulatory policy changes on commission levels.
- Non-life insurance business revenues decreased by 71.8% primarily due to the divestiture of the Baowang online insurance distribution platform.
- A massive provision for credit losses of RMB 1,560.1 million (US$223.1 million) was recognized in 2025, mainly from loans to third parties and consideration receivable from BGM shares.
- An impairment loss on financial assets of RMB 610.6 million (US$87.3 million) was recognized in 2025, primarily on debt securities.
- The company faces ongoing risks of delisting from Nasdaq if its Class A ordinary share price falls below $1.00 for 30 consecutive business days again, as it is no longer eligible for an additional compliance period after the recent share consolidation.
- The dual-class share structure grants Class B ordinary shareholders (primarily Expansion Group Ltd) complete control over voting matters, limiting the influence of Class A ordinary shareholders.
- The company was considered a Passive Foreign Investment Company (PFIC) for U.S. federal income tax purposes for taxable years ended December 31, 2024, 2023, 2022, 2017, and prior years, which could result in adverse tax consequences for U.S. Holders.
Risks
- Failure to successfully implement refined growth strategy or pursue new growth opportunities could adversely affect business and financial results.
- Suspension or changes in contracts with insurance companies could materially and adversely affect business and operating results.
- Inability to attract and retain productive agents, especially entrepreneurial agents, could materially and adversely affect business and operating results.
- Failure of digitalization and technology initiatives could materially and adversely affect business, financial condition, and results of operations.
- Non-compliance with PRC regulations regarding sales personnel registration with the NFRAs Insurance Intermediaries Regulatory Information System (IIRIS) could adversely affect business.
- Changes in the regulatory environment in China, including stricter requirements on product pricing, commission structures, and sales practices, have materially affected and may continue to adversely affect business and results of operations.
- Unsuccessful identification, completion, or integration of acquisitions, or underperformance of acquired companies, could adversely affect growth.
- Intense competition in the insurance intermediary industry from existing and new market participants could lead to loss of customers and negatively affect financial results.
- Decreases in insurance premiums, commission, or fee rates set by insurance companies could have an adverse effect on results of operations.
- Quarterly and annual variations in commission and fee revenue due to seasonality and regulatory changes may unexpectedly impact results of operations.
- Operating structure may make it difficult to respond quickly to operational or financial problems, negatively affecting financial results.
- Future success depends on the continuing efforts of senior management and other key personnel; loss of their services could harm the business.
- Salesperson and employee misconduct is difficult to detect and deter and could harm reputation or lead to regulatory sanctions or litigation costs.
- Investments in certain financial products may not yield anticipated benefits or may incur financial loss, adversely affecting cash position.
- Failure to maintain an effective system of internal control over financial reporting could lead to inaccurate financial results or fraud.
- Potential legal action by former employers or principals of entrepreneurial agents who join the distribution and service network.
- Requirement to write down goodwill could materially and adversely affect financial condition and results.
- Preparing and forecasting financial results requires judgments and estimates which may differ materially from actual results.
- Significant failure in information technology systems, cyber-attacks, or security breaches could disrupt business, lead to loss of customers, damage reputation, and result in liability.
- Exposure to insurance company partner concentration risks due to dependence on a single or limited number of partners.
- Inability to respond in a timely and cost-effective manner to rapid technological change in the insurance intermediary industry.
- Risks related to natural disasters, health epidemics, and other outbreaks could significantly disrupt operations.
- Risk of securities class action litigation, especially given past short-selling reports and lawsuits.
- Exposure to adverse actions by other parties, including lawsuits, negative reports, and regulatory proceedings.
- Inability to meet obligations under bank borrowing arrangements could have a material adverse impact on reputation and financial stability.
- Exposure to risks associated with uncertainty in collectability of loan receivables and other receivables, potentially leading to additional impairment charges.
- Harm to reputation or failure to enhance brand recognition could materially and adversely affect business.
- If the PRC government determines that historical contractual arrangements with former VIEs did not comply with regulations, or if regulations change, shares may decline in value or become worthless.
- Historical contractual arrangements with former consolidated VIEs may be subject to scrutiny by PRC tax authorities, potentially leading to additional taxes.
- The PRC government has significant authority to exert influence on China operations, and changes in economic, political, or social conditions or government policies could materially and adversely affect business.
- Extensive and evolving legal developments in China, non-compliance with which, or changes in which, may materially and adversely affect business and prospects.
- Uncertainty regarding oversight by the Cyberspace Administration of China (CAC) and its impact on business, potentially leading to interruptions or liabilities.
- PRC regulation of loans and direct investment by offshore holding companies to PRC entities may delay or prevent funding, affecting liquidity and business expansion.
- The approval of and filing with the CSRC or other PRC government authorities may be required for future offshore offerings, capital raising activities, and acquisitions, with uncertainties regarding approval timelines and outcomes.
- Uncertainties in the PRC legal system and the interpretation and enforcement of PRC laws and regulations could limit legal protections and disrupt business operations.
- A downturn in the Chinese or global economy could have a material adverse effect on business.
- Governmental control of currency conversion may affect the value of investment.
- The PRC Enterprise Income Tax Law may increase the enterprise income tax rate applicable to some PRC subsidiaries.
- Global income or dividends from PRC subsidiaries may be subject to PRC tax under the EIT Law.
- Reliance on dividends and other distributions from PRC subsidiaries to fund cash and financing requirements, with limitations on their ability to make payments.
- PRC regulations relating to offshore special purpose companies by PRC residents and employee stock options may increase administrative burden or restrict investment activity.
- Fluctuation in the value of the RMB may have a material adverse effect on investment.
- Certain PRC regulations could make it more difficult to pursue growth through acquisitions.
- The PCAOB had historically been unable to inspect auditors in relation to audit work performed for financial statements, depriving investors of inspection benefits.
- Shares may be prohibited from trading in the United States under the HFCA Act in the future if the PCAOB is unable to inspect or investigate completely auditors for two consecutive years.
- The trade price of Class A ordinary shares may be volatile.
- Under the dual-class share structure, holders of Class B ordinary shares have complete control of the outcome of matters put to a vote of shareholders, limiting Class A shareholder influence.
- The dual-class structure may adversely affect the trading market for Class A ordinary shares.
- Need for additional capital, and the sale of additional shares or other equity securities could result in additional dilution to shareholders.
- Substantial future sales or perceived potential sales of ordinary shares or other equity securities in the public market could cause the price of shares to decline.
- Corporate actions are substantially controlled by principal shareholders, officers, and directors.
- Certain judgments obtained against the company by shareholders may not be enforceable.
- Rights of shareholders may be more limited than those of shareholders of a company organized in the United States due to Cayman Islands law.
- Ability to create and issue new classes or series of shares without shareholder approval could delay, deter, or prevent a change in control.
- Corporate articles contain anti-takeover provisions that could discourage a third party from acquiring the company.
- Shareholders may have to rely primarily on price appreciation of Class A ordinary shares for any return on investment, as dividend distribution is discretionary.
- As a foreign private issuer, the company is exempt from certain disclosure requirements under the Exchange Act, affording less protection to shareholders.
- As a Cayman Islands company, the company is permitted to adopt certain home country practices in relation to corporate governance matters that differ significantly from Nasdaq standards, affording less protection to shareholders.
- Investors may face difficulties in protecting their interests and enforcing rights through U.S. federal courts due to incorporation under Cayman Islands law and operations in China.
- The company may be a passive foreign investment company (PFIC) for United States federal income tax purposes, which could result in adverse tax consequences to United States Holders.
Future Outlook
The company expects its life insurance business to continue to represent a high percentage of total net revenues in the next several years, driven by demand for traditional life and health insurance products due to an aging population, increasing insurance awareness, and improved sales professional productivity. Net revenues from non-life products are expected to remain stable. Operating costs as a percentage of total net revenues are anticipated to stabilize, and general and administrative expenses are projected to decrease due to cost-saving initiatives. The company anticipates funding future capital expenditures, including selective acquisitions and investments in sales force training and digital empowerment, primarily with net cash flows from financing and operating activities. However, the company acknowledges that actual results may differ materially from expectations due to evolving regulatory and competitive environments and inherent limitations in predicting the future.
Management Comments
- "Our ability to grow is now dependent on the successful management of this streamlined operations model."
- "We remain committed to strengthening our AI and data capabilities, advancing the professionalism of our advisory teams, expanding online and offline distribution channels, and deepening integration across our ecosystem to drive industry consolidation and unlock sustained value creation."
- "We believe that our current cash and cash equivalents and anticipated cash flow from operations will be sufficient to meet our anticipated cash needs, including our cash needs for working capital and capital expenditures, for at least the next 12 months."
Industry Context
StockSavvy.ai notes that AIFU Inc.'s strategic shift towards AI-driven financial services and core insurance agency business aligns with broader industry trends in China, where an aging population and expanding middle class are driving demand for retirement, health, and wealth management solutions. The divestiture of non-core assets like online distribution and claims adjusting reflects a common corporate strategy to enhance focus and efficiency in a highly competitive and evolving regulatory landscape. However, the significant decline in revenues and substantial credit/impairment losses highlight the severe challenges faced by insurance intermediaries in China, particularly due to tightened regulatory controls on product pricing and commission structures, which have impacted profitability across the sector. The company's emphasis on digital transformation and professionalizing its sales force is crucial for navigating these pressures and competing with both traditional insurers and emerging online platforms.
Comparison to Industry Standards
- The significant decline in net revenues (58.2%) and the substantial net loss (RMB 2.27 billion) in 2025 indicate a performance significantly below industry growth trends, especially when compared to more stable or growing insurance intermediaries in developed markets or even some Chinese counterparts that have adapted more effectively to regulatory changes.
- The massive increase in provision for credit losses (RMB 1,560.1 million) and impairment loss on financial assets (RMB 610.6 million) suggests a higher risk exposure and potentially weaker asset quality compared to industry benchmarks, where such large write-downs are typically indicative of severe underlying issues or aggressive past investment strategies.
- The 400-for-1 reverse share split to regain Nasdaq compliance, while successful, points to a historical share price underperformance that is generally not seen in well-performing industry leaders like Ping An Insurance (Group) Company of China, Ltd. or China Life Insurance Company Limited, which maintain robust market valuations.
- The company's shift to an AI-driven digital ecosystem is a positive step, mirroring global trends seen in companies like Lemonade or ZhongAn Online P&C Insurance, which leverage technology for efficiency and customer engagement. However, the financial results suggest that the benefits of this transformation have not yet materialized to offset the revenue and asset quality challenges.
- The concentration risk with top insurance partners, where Sinatay Life Insurance Co., Ltd. accounted for 13.5% of net revenues in 2025, is a common but notable risk factor in the intermediary sector, potentially higher than more diversified global brokers like Marsh & McLennan Companies or Aon plc.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Executive Officer and Vice-Chairperson of the Board of Directors | NA | Mingxiu Luan | April 2025 | Strategic positioning and leadership transition. |
| Chief Financial Officer | NA | Huaguang Huang | January 2025 | Leadership transition. |
| Independent Director | NA | Kunlin Li | December 2025 | Appointment to the board. |
| Independent Director | NA | Changfu Li | September 2024 | Appointment to the board. |
| Independent Director | NA | Jianyun Ye | January 2025 | Appointment to the board. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Share Structure Amendment | Adopted a dual-class share structure on October 31, 2024, with Class A ordinary shares having one vote and Class B ordinary shares having one hundred votes. | October 31, 2024 | Concentrates voting power with Class B shareholders, potentially limiting influence of Class A shareholders and discouraging change-of-control transactions. |
| Share Consolidation | Implemented a 400-for-1 share consolidation on May 21, 2025, to increase share price and regain Nasdaq compliance. | May 21, 2025 | A reactive measure to maintain listing, but under new Nasdaq rules, future non-compliance could lead to delisting without a cure period. |
| Board Composition | The board of directors consists of four directors, with a majority and all committee members being independent, in compliance with Nasdaq Listing Rules. | Ongoing | Maintains compliance with Nasdaq independence requirements, promoting oversight and accountability. |
| Audit Committee Oversight | The audit committee oversees risk management processes, cybersecurity policy implementation, and reviews and approves related disclosures. | Ongoing | Strengthens risk management and cybersecurity governance, crucial in the current regulatory environment. |
Legal Proceedings
- The company is currently not a party to any material litigation or legal proceeding that may have a material adverse impact on its business or operations.
- The company has been targeted by short selling reports in the past and became subject to class action lawsuits which were subsequently dismissed or settled.
- The NFRA may from time to time make inquiries and conduct examinations concerning compliance with PRC laws and regulations, which have resulted in administrative sanctions (fines) in the past, though not material.
Related Party Transactions
- In 2025, the company incurred RMB 0.4 million in referral service fees from Maase Inc. (a former controlling shareholder), with no outstanding account receivable as of December 31, 2025.
- During 2025, the company provided a loan of RMB 15.5 million to Maase Inc., of which RMB 1.7 million was repaid, leaving an outstanding receivable of RMB 13.7 million as of December 31, 2025.
- In June 2025, the company disposed of 100% equity interests in Beijing Fanlian Investment Co., Ltd. to Chengdu Puyi Bohui Information Technology Co., Ltd. (a subsidiary of Maase Inc.) for a cash consideration of RMB 14.3 million.
Stakeholder Impact
- **Shareholders (Class A)**: Significant dilution from new share issuances and the dual-class structure limits their voting influence. The substantial net loss and asset impairments will negatively impact shareholder equity and potentially share price.
- **Shareholders (Class B)**: Expansion Group Ltd. gained controlling voting power, providing significant influence over corporate matters.
- **Employees/Sales Agents**: Personnel optimization and decreased sales outlets led to expense savings, but also a reduction in employee count. Forfeiture of MDRT options due to underperformance impacts agent incentives. New management changes may affect internal dynamics.
- **Customers**: The strategic focus on AI-driven solutions and professional advisory teams aims to enhance customer experience and service quality, potentially benefiting policyholders.
- **Creditors**: The significant provision for credit losses and impairment on financial assets raises concerns about the company's asset quality and ability to repay certain loans, potentially increasing risk for creditors.
- **Regulatory Bodies**: The company's compliance with evolving PRC regulations (e.g., NFRA, CSRC, CAC) is critical, and any non-compliance could lead to penalties and operational disruptions.
Next Steps
- Continue strengthening AI and data capabilities.
- Advance the professionalism of advisory teams.
- Expand online and offline distribution channels.
- Deepen integration across the ecosystem to drive industry consolidation.
- Monitor and adapt to evolving PRC regulatory environment, particularly regarding pricing, commissions, and data security.
- Manage and mitigate risks associated with loan receivables and financial investments.
- Address potential future Nasdaq listing compliance challenges.
Key Dates
| Date | Description |
|---|---|
| 1998 | Company founded. |
| 1999 | Commenced operations as an auto insurance distributor. |
| 2001 | Formed China United Financial Services Holdings Limited as offshore holding company. |
| 2002 | Expanded product offerings to include other property and casualty insurance products. |
| 2004-06 | CISG Holdings Ltd. became the holding company through share exchanges. |
| 2006 | Commenced life insurance products distribution. |
| 2007-04 | CNinsure Inc. incorporated in the Cayman Islands. |
| 2007-10-31 | ADSs listed on Nasdaq Global Market under symbol CISG. |
| 2008 | Added claims adjusting services. |
| 2009-10-01 | 2009 Amendments to the Insurance Law became effective. |
| 2010 | Established an insurance brokerage business unit. |
| 2012-10 | Obtained approval to establish an insurance sales service group company (Fanhua Group Company). |
| 2014-08-31 | 2014 Amendments to the Insurance Law became effective. |
| 2015-04-24 | 2015 Amendments to the Insurance Law became effective. |
| 2016-12-06 | Shareholders approved company name change to Fanhua Inc. and ticker symbol changed to FANH. |
| 2017 | Divested P&C insurance agency operations and insurance brokerage segment to focus on life insurance. |
| 2017-09-18 | Board modified dividend policy to quarterly payment schedule with payout ratio of no less than 50% of net operating income. |
| 2018-03 | CBIRC established, replacing CIRC as regulatory authority. |
| 2020-12-28 | NDRC and MOFCOM promulgated Foreign Investment Security Review Measures. |
| 2021-02-01 | Measures for the Supervision of the Internet Insurance Business became effective. |
| 2021-09-01 | Data Security Law became effective. |
| 2021-11-01 | Personal Information Protection Law became effective. |
| 2021-12-16 | PCAOB issued HFCA Act Determination Report, identifying auditors in mainland China and Hong Kong SAR as uninspectable. |
| 2022-02-15 | Measures for Cybersecurity Review Measures took effect. |
| 2022-05 | SEC conclusively identified the company as a Commission-Identified Issuer under the HFCA Act. |
| 2022-08-12 | Board adopted 2022 Share Incentive Plan and approved initial option grants. |
| 2022-12-15 | PCAOB vacated its December 2021 determinations, removing mainland China and Hong Kong SAR from the list of uninspectable jurisdictions. |
| 2023-01-03 | Acquired 57.73% equity interest in Zhongrong Smart Finance Information Technology Co., Ltd. |
| 2023-02-06 | Granted 2023 Million Dollar Round Table Options to high-performing agents. |
| 2023-02-08 | Entered into share purchase agreement to acquire 51% equity interest in Wuhan Taiping Online Insurance Agency Co., Ltd. |
| 2023-03-01 | Acquisition of Jilin Zhongji ShiAn Insurance Agency Co., Ltd. (51% equity) closed. |
| 2023-03-31 | New Overseas Listing Rules took effect. |
| 2023-05 | National Financial Regulatory Administration (NFRA) formed, replacing CBIRC. |
| 2023-08-16 | Board approved grant of restricted share units (RSUs) to a former executive officer. |
| 2023-09-29 | NFRA issued Measures for the Supervision of Insurance Sales Behavior, effective March 1, 2024. |
| 2023-11 | Acquired 100% equity interest in Aasure Insurance Broker Limited. |
| 2023-11-30 | Supplementary agreement for Taiping acquisition, leading to repurchase of shares and surrender of equity interests. |
| 2023-12-27 | Securities exchange agreements with MAASE Inc. and certain shareholders of the company. |
| 2023-12-31 | Transaction with MAASE Inc. closed, making MAASE the controlling shareholder. |
| 2024-01-01 | Effective date for the adoption of ASU 2016-01 (Financial Instruments-Overall). |
| 2024-01-23 | Engaged Enrome LLP as independent registered public accounting firm, dismissed Deloitte Touche Tohmatsu Certified Public Accountants LLP. |
| 2024-02-02 | Share options granted to certain employees and top agents of MAASE Inc. |
| 2024-02-20 | Board adopted 2023 Share Incentive Plan. |
| 2024-03-31 | New Overseas Listing Rules became effective. |
| 2024-04-01 | BWWS Limited disposed of controlling financial interests in BML and Avantech, leading to equity method accounting. |
| 2024-04-16 | Share options granted to certain MDRT agents (2024 MDRT Option 1). |
| 2024-06-25 | Share options granted to certain sales team leaders (2024 Option 2). |
| 2024-07-02 | Share options granted to certain key employees (2024 Option 4). |
| 2024-07-14 | 2024 Option 4 fully exercised. |
| 2024-07-15 | Board approved grant of additional RSUs to a former executive officer. |
| 2024-08-01 | Administrative Provisions on the Account Information of Internet Users became effective. |
| 2024-09 | Changfu Li became independent director. |
| 2024-09-30 | Former executive officer resigned, RSUs vested/forfeited. |
| 2024-10-23 | ADSs commenced trading on Nasdaq under ticker symbol AIFU. |
| 2024-10-31 | Shareholders approved company name change from Fanhua Inc. to AIX Inc. and adopted dual-class share structure. |
| 2024-11-17 | Board approved grant of RSUs to the new chair of the board. |
| 2024-11-27 | Entered into share transfer agreement with BGM Group Limited to exchange equity interests in RONS Technology and Xinbao Investment. |
| 2024-12-04 | All shares exercised under 2024 Option 4 repurchased by the Group. |
| 2024-12-27 | Transferred all interests in Fanhua RONS Technologies and Shenzhen Xinbao Investment Co., Ltd. (former VIEs) to BGM Group Ltd. and terminated VIE contractual arrangements. |
| 2024-12-31 | RONS Technology and Xinbao Investment deconsolidated from financial statements. |
| 2025-01-01 | Effective date for deconsolidation of claims adjusting segment. |
| 2025-01-02 | Issued 2,500,000 Class B ordinary shares to Infinew Limited and MAASE Inc. |
| 2025-01-09 | Acquisition of Nova Lumina Limited completed. |
| 2025-01-23 | Engaged Enrome LLP as independent registered public accounting firm. |
| 2025-02 | Disposed of 100% equity interests in Fanhua Blueplus Health Management Co., Ltd. and Shenzhen Dianlian Information Technology Co., Ltd. |
| 2025-02-14 | Board approved severance compensation package including RSU grants for former officers and employees. |
| 2025-04-17 | Company name changed from AIX Inc. to AIFU Inc. |
| 2025-04-28 | Date of this annual report on Form 20-F. |
| 2025-04-29 | Board approved severance compensation package including RSU grants for a former executive officer. |
| 2025-05-20 | Terminated ADS program and ceased listing of ADSs on Nasdaq. |
| 2025-05-21 | Implemented 400-for-1 share consolidation and Class A ordinary shares commenced trading on Nasdaq. |
| 2025-05-27 | Transferred 53,466,331 Class A ordinary shares of BGM to third-party investment firms. |
| 2025-06 | Disposed of 100% equity interests in Beijing Fanlian Investment Co., Ltd. |
| 2025-06-05 | Nasdaq confirmed compliance with minimum bid price requirement. |
| 2025-07-07 | Entered into definitive share purchase agreement for private placement and warrant offering. |
| 2025-07-23 | Private placement of 10,000,000 Class A ordinary shares completed. |
| 2025-08 | New bank loan facility of RMB 74.0 million obtained. |
| 2025-10-23 | Warrants from private placement became exercisable. |
| 2025-11-07 | Entered into share subscription agreement with Expansion Group Ltd for 5,000,000 Class B ordinary shares. |
| 2025-12 | Kunlin Li became independent director. |
| 2025-12-12 | Entered into transaction agreement to acquire Nova Lumina Limited. |
| 2025-12-22 | Issuance of 5,000,000 Class B ordinary shares to Expansion Group Ltd completed. |
| 2026-01 | Jianyun Ye became independent director. |
| 2026-01-09 | Share issuance for Nova Lumina acquisition completed. |
| 2026-04-28 | Audit report date by Enrome LLP. |
Recommendation
strong sellThe company's financial performance in 2025 is severely negative, marked by a substantial net loss of RMB 2.27 billion, a drastic 58.2% decline in revenues, and massive provisions for credit losses (RMB 1.56 billion) and asset impairments (RMB 610.6 million). These figures indicate significant underlying operational and asset quality issues. While strategic shifts and cost-saving measures are in progress, their positive impact is currently overshadowed by the severe financial deterioration. The dual-class share structure and ongoing regulatory uncertainties in China further add to the investment risk. Given the profound financial distress and high risk profile, a seasoned investor would likely recommend a strong sell.
Keywords
Insurance Agency, Financial Services, China, SEC Filing, 20-F, Nasdaq, Share Consolidation, Net Loss, Credit Losses, Asset Impairment, Strategic Restructuring, AI-driven Platform, Corporate Governance, Cayman Islands, PRC Regulations, Dual-Class Shares, Nova Lumina, Tea Products, Capital Raise
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.